Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Experts say the approval is a positive step toward managing obesity
For a 50mg vial, adding 5ml bacteriostatic water produces 10mg/ml concentration
FDA Approval Criteria: For FDA approval as weight loss medication, drugs must demonstrate: Efficacy Requirements: At least 5% average weight loss greater than placebo At least 35% of patients lose 5% body weight At least 15% of patients lose 10% body weight Safety Requirements: Acceptable safety profile in clinical trials Benefits outweigh risks Appropriate for long-term use All newer GLP-1 medications far exceed the minimum efficacy requirements, which explains their dominance
Additionally, amylin receptor activation influences glucose metabolism and insulin sensitivity, contributing to improved metabolic outcomes beyond weight management alone
